Healthcare Triangle Inc
For the period ended Jun 30, 2024. Filed Aug 19, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 19, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
1) Organization and Description of Business
Healthcare Triangle Inc. (“the Company”) was incorporated under the laws of the State of Nevada on October 29, 2019, and then converted into a Delaware corporation on April 24, 2020, to provide IT and data services to the Healthcare and Life Sciences (‘HCLS”) industry. On January 1, 2020, the Company acquired the Life Sciences Business of SecureKloud Technologies Inc. (“Parent”) and on May 8, 2020, the Company acquired Cornerstone Advisors Group LLC (Healthcare Business) from its Parent.
Company reinforces healthcare progress through breakthrough technology and extensive industry know-how. Company support healthcare providers and payors, hospitals and pharma/life sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility and accelerate responding to immediate business needs and competitive threats. The highly regulated HCLS industry turn to Company for expertise in digital transformation on the cloud, security and compliance, develops, data lifecycle management, healthcare interoperability, clinical and business performance optimization.
Company concentrates on accelerating value to the three healthcare sectors:
| 1. | Pharmaceutical companies, which require improved efficiencies in the clinical trial process. Company modernizes their IT infrastructure to advance the clinical trial process to drug discovery and delivery. |
| 2. | Hospitals and health systems, which face interoperability challenges as mergers, acquisitions and partnerships drive increasing need for integrated healthcare infrastructures. Company’s health IT expertise optimizes providers’ enterprise digital structure needs connecting disparate systems and applying analytics capabilities. |
| 3. | Life sciences, payers and all healthcare organizations must protect and secure personal health information (PHI), a regulatory compliance mandate that Company addresses and manages for its customers. |
As an organization with the deep-rooted cloud expertise, Company’s technology significantly relies on Big Data, Analytics, DevOps, Security/Compliance, Identity Access Management (IAM), Machine Learning (ML), Artificial Intelligence (AI), Internet of Things (IoT) and Blockchain.
Devcool Inc
Devcool Inc (“the Company”) was incorporated under the laws of the State of California on September 25, 2016. The Company solves complex technology problems and delivers innovation to healthcare industry. The Company has successfully implemented projects for top Healthcare insurance companies and hospitals across United States of America. On December 10, 2021, Healthcare Triangle, Inc (the “Company”) entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with Devcool, Inc., a California corporation (“Devcool”), Go To Assistance Inc., a California corporation (“Seller”), and Mr. Sandeep Deokule, current Chief Executive Officer of Devcool (“SD”). Pursuant to the Share Purchase Agreement, the Company will acquire 5,000,000 shares of Devcool’s Class B Common Stock, par value $0.00001, which represents all of the issued and outstanding capital stock of Devcool (the “Acquisition”). The closing of the Acquisition occurred on December 10, 2021 (the “Closing Date”). The Company exercised control by virtue of taking over the operations from November 01, 2021 (effective date) and the financials have been consolidated from this date.
Impact of the COVID-19 Pandemic
COVID-19 has created uncertainty for our employees, members, and customers. We consider the impact of the pandemic on our business by evaluating the health of our operations, any changes to our revenue outlook, and the degree to which interest in Company’s solutions have evolved during these unprecedented times. We measure our performance through several key metrics; and as gauged these performance metrics, service levels have been high, and customer engagement and satisfaction have remained strong through these tough times. While the COVID-19 pandemic has not had a material adverse impact on our financial condition and results of operations to date, the future impact of the COVID-19 outbreak on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers and our sales cycles, impact on our marketing efforts, and any reduction in spending by our customers, all of which are uncertain and cannot be predicted. We have a diverse set of customers, while some have faced headwinds, others have experienced growth. Because of COVID-19, Healthcare and Life Sciences organizations are accelerating research, rethinking patient care, and maintaining clinical and operational continuity during this unprecedented time for the global health system. COVID-19 has necessitated the adoption of digital communication channels and remote working technology within the Healthcare and Life Sciences industry at a rapid pace and our proprietary platforms and solutions addresses these challenges. Our business is focused on providing digital platform solutions to healthcare organizations and it is our mission to adequately address COVID-19 challenges for the benefit of our customers and society in general. As a result, consumers have better personal care, convenience, and value. COVID-19 is expected to drive increased utilization of technology during and after the pandemic, and such shift to a virtual approach creates a unique opportunity for our business to shape the new virtual-oriented experiences of businesses through our cloud technology and services and our value proposition resonates with a broader audience of companies as they turn their focus to safely reopening their workplaces and managing the ongoing health and well-being of employees and their families.
2) Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company’s operating losses raise substantial doubt about its ability to continue as a going concern and the financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The Company entered into an ATM Sales Agreement (“ATM Agreement”) with Dawson James Securities, Inc. (the “DJ ATM”) pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-276382), which was declared effective by the U.S. Securities and Exchange Commission on January 31, 2024. Pursuant to the ATM Agreement, the Company sells newly issued shares into the trading market through our designated sales agent at prevailing market prices. As of the date of this Plan, the Company has sold $956,000 of shares through the DJ ATM. The Company currently has $1,444,000 of capacity under the DJ ATM and, market conditions permitting, plans to sell off its entire capacity within the next few months and then amend the DJ ATM to increase capacity enabled by additional shares included in the public float from the prior ATM sales. The Company projects this increased capacity could be approximately $500,000.
The Company and an institutional investor, (“Investor”), entered into a securities purchase agreement on December 28, 2023 to issue to the Investor senior secured 15% original issue discount convertible promissory notes (the “Notes”) in the aggregate principal amount of up to $5,200,000 which will result in gross proceeds to the Company in the amount of up to $4,420,000 due to the original issue discount, and warrants (the “Warrants”). Further to the first tranche therein, the Company issued a Note to the Investor in the principal amount of $2,000,000, of which the Company has repaid an amount equal to $1,181,250, vide issuance of its registered Common Stock to the amount of 749,004 shares of common stock leading to an increase in stockholder equity to the tune of $1,181,250. The Company anticipates repaying the entire obligations under its first tranche by or before December 31, 2024.
The Parent Company, SecureKloud Technologies, Inc, is willing to invest $5 million additional equity through FY24 to support the Company’s working capital and investment requirements.
3) Summary of Significant Accounting Policies
Basis of consolidated financial statements
The accompanying condensed consolidated financial statements include the accounts of Healthcare Triangle and its wholly owned subsidiary. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. All intercompany balances and transactions have been eliminated in consolidation.
The accompanying statements of operations include expenses for certain functions historically performed by the Parent company, including general corporate services, such as legal, accounting, treasury, information technology, human resources and administration. These expenses are based primarily on direct usage when identifiable, direct capital expenditures or other relevant allocations during the respective periods. We believe the assumptions underlying the accompanying condensed consolidated financial statements, including the assumptions regarding these expenses from this related party, are reasonable. Actual results may differ from these expenses, assumptions and estimates. The amounts recorded in the accompanying condensed consolidated financial statements are not necessarily indicative of the actual amount of such indirect expenses that would have been recorded had we been a separate independent entity.
Unaudited Interim Financial Information
The accompanying unaudited condensed consolidated financial statements and the related footnote disclosures have been prepared by us in accordance with GAAP for interim financial reporting and as required by Rule 10-01 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements may not include all of the information and notes required by GAAP for audited financial statements. The year-end December 31, 2023 condensed consolidated balance sheet data included herein was derived from audited financial statements but does not include all disclosures required by GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of items of a normal and recurring nature, necessary to present fairly our financial position as of June 30, 2024, the results of operations, comprehensive income (loss), stockholders’ deficit, and cash flows for the three months ended June 30, 2024 and 2023. The results of operations for the three months ended June 30, 2024 and 2023 are not necessarily indicative of the results to be expected for the full year. The information contained herein should be read in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC. Management considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through the date of issuance of these financial statements.
Accounting Policies
Use of Estimates
The preparation of financial statements is in conformity with GAAP, which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:
| ● | the standalone selling price for each distinct performance obligation |
| ● | the determination of the period of benefit for amortization of deferred costs. |
| ● | the fair value of assets acquired, and liabilities assumed for business combinations. |
| ● | Share based compensation including warrants |
Emerging Growth Company Status
We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of (i) December 21, 2026 (the last day of the fiscal year following the fifth anniversary of our IPO), (ii) the last day of the first fiscal year in which we have total annual gross revenue of at least $1.07 billion, (iii) the last day of the first fiscal year in which we are deemed to be a “large accelerated filer”, as defined in the rules under the Exchange Act, and (iv) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. We refer to the Jumpstart Our Business Startups Act of 2012 herein as the “JOBS Act,” and any reference herein to “emerging growth company” has the meaning ascribed to it in the JOBS Act.
We have elected to take advantage of certain of the reduced disclosure obligations in this Annual Report on Form 10-K and may elect to take advantage of other reduced reporting requirements in our future filings with the SEC. As a result, the information that we provide to our stockholders may be different from the information you might receive from other public reporting companies in which you hold equity interests. In particular, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the Securities Act) for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this extended transition period and, as a result, so long as we remain an emerging growth company, we will not be subject to the same implementation timing of new or revised accounting standards as other public companies that are not emerging growth companies until these standards apply to private companies unless we elect to early adopt as permitted by the relevant guidance for private companies.
Segment Information
The management has chosen to organize the Company around differences in products and services and segregated the reporting segments as Software Services, Managed Services and Support, and Platform Services.
Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assessing performance. The Company defines the term ‘chief operating decision maker’ to be the Chief Financial Officer. The Chief Financial Officer along with the management team reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating our financial performance. Accordingly, the Company has determined that it operates in three distinct reportable operating segments, and all required financial segments information can be found in the consolidated financial statements.
Expenses included in segment operating profit consist principally of direct selling, delivery costs and research and development expenses. Certain Sales and Marketing expenses, General and Administrative expenses, depreciation, and amortization are not allocated to individual segments in internal management reports used by the chief operating decision maker. Accordingly, such expenses are excluded from segment operating profit and are included below as “unallocated costs” and adjusted against our total income from operations. Additionally, management has determined that it is not practical to allocate identifiable assets by segment, since such assets are used interchangeably among the segments.
Schedule of operating segment
| Three months Ended June 30, · Changes | ||||
|---|---|---|---|---|
| (In thousands) | ||||
| 2024 | 2023 | Amount | % | |
| Software Services | $663 | $5,185 | $(4,522) | (87)% |
| Managed Services and Support | 2,253 | 2,865 | (612) | (21)% |
| Platform Services | 68 | 476 | (408) | (86)% |
| Revenue | $2,984 | $8,526 | $(5,542) | (65)% |
| Six months Ended June 30, · Changes | ||||
|---|---|---|---|---|
| (In thousands) | ||||
| 2024 | 2023 | Amount | % | |
| Software Services | $2,235 | $11,643 | $(9,408) | (81)% |
| Managed Services and Support | 4,724 | 5,906 | (1,182) | (20)% |
| Platform Services | 134 | 815 | (681) | (84)% |
| Revenue | $7,093 | $18,364 | $(11,271) | (61)% |
Operating profit by Operating Segment
| Three months Ended June 30, · Changes | ||||
|---|---|---|---|---|
| (In thousands) | ||||
| 2024 | 2023 | Amount | % | |
| Software Services | $(170) | (644) | 474 | 74% |
| Managed Services and Support | 706 | 822 | (116) | (14)% |
| Platform Services | (181) | 84 | (265) | 315% |
| Total segment operating (loss) profit | 355 | 262 | 93 | 35% |
| Less: unallocated costs | 1,733 | 1,857 | (124) | (7)% |
| Income (loss) from operations | (1,378) | (1,595) | 217 | 14% |
| Other Income | — | — | — | 0% |
| Interest expense | (131) | (186) | 55 | 30% |
| Net income (loss) before income tax expenses | $(1,509) | (1,781) | 272 | 15% |
| Six months Ended June 30, · Changes | ||||
|---|---|---|---|---|
| (In thousands) | ||||
| 2024 | 2023 | Amount | % | |
| Software Services | $(1,000) | (1,779) | 779 | 44% |
| Managed Services and Support | 1,763 | 1,374 | 389 | 28% |
| Platform Services | (298) | (379) | 81 | 21% |
| Total segment operating (loss) profit | 465 | (784) | 1,249 | 159% |
| Less: unallocated costs | 3,552 | 4,020 | (468) | (12)% |
| Income (loss) from operations | (3,087) | (4,804) | 1,717 | 36% |
| Other Income | — | 12 | (12) | (100)% |
| Interest expense | (279) | (248) | (31) | (13)% |
| Net income (loss) before income tax expenses | $(3,366) | (5,040) | 1,674 | 33% |
Revenue from top 5 customers
Three Months Ended June 30, 2024
| Customer | Amount (In thousands) | % of Revenue |
|---|---|---|
| Customer 1 | $925 | 31% |
| Customer 2 | 486 | 16% |
| Customer 3 | 221 | 7% |
| Customer 4 | 215 | 7% |
| Customer 5 | $193 | 7% |
Three Months Ended June 30, 2023
Schedule of concentration
| Customer | Amount (In thousands) | % of Revenue |
|---|---|---|
| Customer 1 | $4,519 | 53% |
| Customer 2 | 912 | 11% |
| Customer 3 | 622 | 7% |
| Customer 4 | 539 | 6% |
| Customer 5 | $319 | 4% |
Six Months Ended June 30, 2024
| Customer | Amount (In thousands) | % of Revenue |
|---|---|---|
| Customer 1 | $1,645 | 23% |
| Customer 2 | 962 | 14% |
| Customer 3 | 851 | 12% |
| Customer 4 | 710 | 10% |
| Customer 5 | $547 | 8% |
Six Months Ended June 30, 2023
| Customer | Amount (In thousands) | % of Revenue |
|---|---|---|
| Customer 1 | $9,449 | 51% |
| Customer 2 | 1,771 | 10% |
| Customer 3 | 1,330 | 7% |
| Customer 4 | 984 | 5% |
| Customer 5 | $920 | 5% |
Revenue Recognition
We recognize revenues as we transfer control of deliverables (services, solutions, and platform) to our clients in an amount reflecting the consideration to which we expect to be entitled. To recognize revenues, we apply the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenues when a performance obligation is satisfied. We account for a contract when it has approval and commitment from all parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. We apply judgment in determining the customer’s ability and intention to pay based on a variety of factors including the customer’s historical payment experience.
For performance obligations where control is transferred over time, revenues are recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided.
Software Services
The Company enters into contractual obligations with the customers to perform (i) Strategic advisory services which include assessment of the enterprise network, applications environment and advise on the design and tools; (ii) Implementation services which include deployment, upgrades, enhancements, migration, training, documentation and maintenance of various electronic health record systems and (iii) Development services which include customization of network and applications in the public cloud environment.
Revenue from Strategic advisory, Implementation and Development services are distinct performance obligation and is recognized on time-and-material or fixed-price project basis. Revenues related to time-and-material are recognized over the period the services are provided using labor hours. Revenues related to fixed-price contracts are recognized as the service is performed using the cost-to-cost method, under which the total value of revenues is recognized based on the percentage that each contract’s total labor cost to date bears to the total expected labor costs. The cost-to-cost method requires estimation of future costs, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately, where appropriate.
We may enter into contracts that consist of multiple performance obligations. Such contracts may include any combination of our deliverables. To the extent a contract includes multiple promised deliverables, we apply judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For contracts with multiple distinct performance obligations, we allocate consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which we would sell a promised good or service separately to the customer. When not directly observable, we estimate standalone selling price by using the expected cost plus a margin approach. We establish a standalone selling price range for our deliverables, which is reassessed on a periodic basis or when facts and circumstances change.
Managed Services and Support
The Company has standard contracts for its Managed Services and Support, however the statement of work contained in such contracts is unique for each customer. A typical Managed Services and Support contract would provide for some or all of the following types of services being provided to the customer: Cloud hosting, Continuous monitoring of applications, security and compliance and support.
Revenue from Managed services and support is a distinct performance obligation and recognized based on SSP (standalone selling price), ratably on a straight-line basis over the period in which the services are rendered. Contract with customers includes subcontractor services or third-party cloud infrastructure services in certain integrated services arrangements. In these types of arrangements, revenue is recognized net of costs when the Company is acting as an agent between the customer and the vendor, and gross when the Company is the principal for the transaction. In doing so, the Company first evaluates whether it controls the platform or service before it is transferred to the customer. The Company considers whether it has the primary obligation to fulfil the contract, pricing discretion and other factors to determine whether it controls the platform or service and therefore is acting as a principal or an agent. Payment for managed services and support is due monthly.
Platform Services
The Company has standard contracts for its Platform Services, however the statement of work contained in such contracts is unique for each customer. A typical Platform Services contract would provide for some or all of the following types of services being provided to the customer: Data Analytics, Backup and Recovery, through our Platform.
The revenue from Platform services is a distinct performance obligation and recognized based on SSP. During the periods presented the Company generated revenue from Platform services on a fixed-price solutions delivery model. Revenues related to fixed-price contracts are recognized as the service is performed using the cost-to-cost method, under which the total value of revenues is recognized based on the percentage that each contract’s total labor cost to date bears to the total expected labor costs. The cost-to-cost method requires estimation of future costs, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately, where appropriate.
Our contractual terms and conditions for Software services, Managed Services and Support and Platform services mandate that our services are documented and subject to inspection, testing at the time of delivery to customer. In addition, the Company needs to integrate seamlessly into the customers’ systems. Also, the customer has a right to cancel all, or part of the services rendered if it is not in accordance with statement of work and within the stipulated time.
Contract Balances
The timing of revenue recognition, billings, and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms, generally monthly upon achievement of contractual milestones. Generally, billing occurs after revenue recognition, resulting in contract assets. However, we sometimes receive advances or deposits from our customers, particularly on our international contracts, before revenue is recognized, resulting in contract liabilities. These deposits are liquidated when revenue is recognized
The beginning and ending contract balances were as follows:
Schedule of receivables and contract liabilities
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (In thousands) | ||
| Accounts Receivable | 2,005 | 3,236 |
Cash and Cash Equivalents
The Company considers all highly liquid investments (including money market funds) with an original maturity at acquisition of three months or less to be cash equivalents. The Company maintains cash balances, which may exceed federally insured limits. The Company does not believe that this results in any significant credit risk.
Accounts Receivable
The Company extends credit to clients based upon the management’s assessment of their creditworthiness on an unsecured basis. The Company provides an allowance for uncollectible accounts based on historical experience and management evaluation of trend analysis. The Company includes any balances that are determined to be uncollectible in its allowance for doubtful accounts. For the quarter ended June 30, 2024 the Company did not provided an allowance for uncollectible accounts and year ended December 31, 2023 the Company provided $222 as allowances for uncollectible accounts. Based on the information available, management believes the Company’s accounts receivable are collectible.
Property and Equipment
Property and equipment are stated at cost. The Company provides for depreciation of property and equipment using the straight-line method over the estimated useful lives of the related assets ranging from 3 to 7 years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease terms or the useful lives of the improvements. The Company charges repairs and maintenance costs that do not extend the lives of the assets to expenses as incurred.
Intangible Assets
We capitalize certain costs incurred for the platform development when it is determined that it is probable that the platform will be completed and will be used as intended. Costs related to preliminary project activities, post-implementation activities, training, and maintenance are expensed as incurred. Customer relationship and platform development are amortized based on finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the asset will be utilized. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.
Goodwill
Goodwill is the excess of the cost of an acquired entity over the net amounts assigned to tangible and intangible assets acquired and liabilities assumed. Goodwill is not amortized but is subject to an annual impairment test.
The Company performs its annual goodwill impairment test on an annual basis in the fourth quarter of each fiscal year or more frequently if changes in circumstances or the occurrence of events suggest that an impairment exists. If the fair value of the reporting unit is less than its carrying value, an impairment loss is recorded to the extent that the implied fair value of the reporting unit’s goodwill is less than the carrying value of the reporting unit’s goodwill. The company fully impaired goodwill in Q4 FY 2023 due to the loss of a major customer.
The Company’s quarterly goodwill impairment test resulted in no impairment charges in the quarter ended June 30, 2024 and 2023.
Allowance for Doubtful Accounts
Trade accounts receivable is stated at the amount the Company expects to collect and do not bear interest. The collectability of trade receivable balances is regularly evaluated based on a combination of factors such as customer creditworthiness, past transaction history with the customer, current economic industry trends and changes in customer payment pattern. Additionally, if it is determined that a customer will be unable to fully meet its financial obligation, such as in the case of a bankruptcy filing or other material event impacting its business, a specific allowance for doubtful accounts may be recorded to reduce the related receivable to the amount expected to be recovered.
Although we believe that our approach to estimates and judgments regarding our allowance for doubtful accounts is reasonable, actual results could differ and we may be exposed to increases or decreases in required allowances that could be material.
Business Combinations
As per ASC 805-50 a common-control transaction does not meet the definition of a business combination because there is no change in control over the net assets. The accounting for these transactions are addressed in the “Transactions Between Entities Under Common Control”. The net assets are derecognized by the transferring entity and recognized by the receiving entity at the historical cost of the parent of the entities under common control. Any difference between the proceeds transferred or received and the carrying amounts of the net assets is recognized in equity in the transferring and receiving entities’ separate financial statements and eliminated in consolidation. The change in accounting principle is applied retroactively for all periods presented.
We account for business combinations using the acquisition method, which requires the identification of the acquirer, the determination of the acquisition date and the allocation of the purchase price paid by the acquirer to the identifiable tangible and intangible assets acquired, the liabilities assumed, including any contingent consideration and any non-controlling interest in the acquiree at their acquisition date fair values.
Goodwill represents the excess of the purchase price over the fair value of net assets acquired, including the amount assigned to identifiable intangible assets. Identifiable intangible assets with finite lives are amortized over their useful lives. Acquisition-related costs are expensed in the periods in which the costs are incurred. The results of operations of acquired businesses are included in our consolidated financial statements from the date of effective control.
Valuation of Contingent Earn-out Consideration.
Acquisitions may include contingent consideration payments based on the achievement of certain future financial performance measures of the acquired company. Contingent consideration is required to be recognized at fair value as of the acquisition date. We estimate the fair value of these liabilities based on financial projections of the acquired companies and estimated probabilities of achievement. We believe our estimates and assumptions are reasonable, however, there is significant judgment involved. We evaluate, on a routine, periodic basis, the estimated fair value of the contingent consideration and changes in estimated fair value, subsequent to the initial fair value estimate at the time of the acquisition, will be reflected in income or expense in the consolidated statements of operations. Changes in the fair value of contingent consideration obligations may result from changes in discount periods and rates, changes in the timing and amount of revenue and/or earnings estimates and changes in probability assumptions with respect to the likelihood of achieving the various earn-out criteria. Any changes in the estimated fair value of contingent consideration may have a material impact on our operating results.
Earnings (Loss) Per Share.
Earnings per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to Section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.
Fair Value Measurements
The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:
Level 1—Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2—Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.
Level 3—Inputs that are unobservable
Money market funds and U.S. treasury securities are classified within Level 1 because they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Other debt securities and investments are classified within Level 2 if the investments are valued using model driven valuations which use observable inputs such as quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Available-for-sale debt securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. In connection with the acquisition of Devcool, Inc., the Company recognized a liability on the acquisition date for the estimated fair value of the contingent consideration based on the probability of achieving certain milestones pursuant to the acquisition agreement. The fair value measurement of the contingent consideration is based on significant unobservable inputs and management judgment; therefore, it is categorized under Level 3 at the balance sheet date in the table below.
Schedule of balance sheet
| Fair Value Measured Using | ||||
|---|---|---|---|---|
| (In thousands) | ||||
| Level 1 | Level 2 | Level 3 | Total | |
| Financial liabilities: | ||||
| Warrant Liabilities | $1,333 | $1,333 | ||
| Acquisition-related contingent consideration | — | — | $500 | $500 |
Stock-Based Compensation
The Company accounts for stock-based awards to employees and consultants in accordance with applicable accounting principles, which requires compensation expense related to share-based transactions, including employee stock options, to be measured and recognized in the financial statements based on a determination of the fair value of the stock options over the instruments vesting period. Options awarded to purchase shares of common stock issued to non-employees do not need to be remeasured as per ASU 2018-07 principles.
The Company adopted the “2020 Stock Incentive Plan” (Plan). The Company has reserved 861,764 shares of the Company’s Common stock.
Income taxes
The provision for income taxes was determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the period. Deferred taxes result from differences between the financial and tax basis of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates applicable in the years in which they are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date.
Advertising Costs
The Company expenses advertising cost as incurred. Advertising expense for the quarters ended June 30, 2024 and 2023 were $145 and $97 respectively.
Concentrations
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade receivables. Credit risks associated with trade receivables is minimal due to the Company’s customer base which consist of large customer base and ongoing procedures, which monitor the credit worthiness of its customers. For the quarter ended June 30, 2024 and 2023 revenue from the top five customers accounted for approximately 68% and 81% of total revenue respectively. For the quarter ended June 30, 2024 and year ended December 31, 2023 accounts receivable from five major customers accounted for approximately 72% and 78% of the total accounts receivables.
The Company maintains cash balances in various financial institutions. The balances are generally insured by the Federal Deposit Insurance Corporation up to $250,000 (valid through June 30, 2024) per institution.
As of June 30, 2024 and December 31, 2023, the Company had $0 and $667 respectively, of uninsured cash balances. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.
4) Property and Equipment
Property and equipment consisted of the following:
Schedule of property and equipment
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| (In thousands) | ||
| Furniture and Equipment | $132 | $132 |
| Less: Accumulated depreciation | (108) | (88) |
| Net Fixed Assets | $24 | $44 |
Depreciation expenses for the quarter ended June 30, 2024, and June 30, 2023 were $9 and $10 respectively.
5) Intangible Assets
The Company’s intangible assets consist primarily of intellectual property and customer relationship it acquired through various acquisitions. We capitalize certain costs incurred for the platform development when it is determined that it is probable that the platform will be completed and will be used as intended. We amortize our intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the asset will be utilized.
Intangible assets consist of the following:
| June 30, 2024 · December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|
| Weighted average Remaining Useful life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |
| (In thousands) · (In thousands) | |||||||
| Customer relationships | 0 | $8,081 | $8,081 | — | $8,081 | $8,081 | $— |
| Intellectual property | 2.76 | 7,329 | 4,028 | 3,301 | 7,329 | 3,357 | 3,972 |
| Product development | 0 | 477 | 477 | — | 477 | 477 | — |
| Total Intangible Assets | $15,887 | $12,586 | $3,301 | $15,887 | $11,915 | $3,972 | |
Amortization expense for the quarter ended June 30, 2024 and June 30, 2023 were $336 and $792 respectively. This amortization expense relates to capitalized software expenses, intellectual property, and customer lists.
Schedule of intangibles asset useful life
| Nature of Intangibles | Useful Life |
|---|---|
| Customer relationships | 5 years |
| Intellectual property | 5 years |
| Product development | 5 years |
Estimated annual amortization expense (including amortization expense associated with capitalized software costs) for each of the next six years are as follows:
Schedule of amortization expense
| June 30, | |
|---|---|
| 2024 | $672 |
| 2025 | 1,343 |
| 2026 | 1,286 |
| 2027 | — |
| Total | $3,301 |
6) Due from Related Party
Securekloud Technologies Inc, (Parent) is a Nevada based corporation, focusing on digital transformation for Avionics, Technology and Manufacturing Industry. As a pioneer in enabling cloud transformation for global enterprises, Securekloud Technologies Inc is building on foundation of cloud capabilities by creating innovative platforms that are time-tested and designed to drive success in its digital transformation journey. HTI uses the capabilities and resources of the parent for the execution of the projects for its customers.
Securekloud Technologies Inc owns 45.40% of Healthcare Triangle Inc as of June 30, 2024.
The Company entered into a Master Service Agreement, Shared Services Agreement and Rental Sublease Agreement with its parent. As per the Master Services Agreement, parent provides technical resources according to the statement of work from the Company. The initial term of the agreement is twenty-four months, which is extendable based on mutual consent. The parent charges for the services at cost. The Company received services amounting to $755 and $756 for the quarter ended June 30, 2024, and 2023 respectively. The Company has paid for these services during the year.
As per the terms of the Shared Services and Rental Sublease Agreement, the costs incurred by the parent on behalf of the Company are settled at cost. The Shared Services Agreement includes Development infrastructure, Sales support, Recruitment and Immigration support, Project coordination, HR and Operation support, Management /Advisory services. The Company received services amounting to $52 and $71 for the quarter ended June 30, 2024, and 2023 respectively. The Company has paid for these services during the year.
The Company does not have any signed lease agreement on its name and currently operates from two office locations leased by the Parent. The Company has entered into a sublease agreement with the Parent and paid rent of $34 and $67 for the quarter ended June 30, 2024, and 2023 respectively.
The Company has earned $13 from sale to related parties for the quarter ended June 30, 2024, and $9 for the quarter ended June 30, 2023.
7) Business Combination
Effective May 8, 2020, the Company acquired the entire equity of Cornerstone Advisory Services LLC in exchange for a promissory note. In accordance with the terms of the Equity Purchase Agreement dated May 8, 2020, the Company acquired 100% of the equity of Cornerstone Advisory Services LLC for a total consideration of $7,000. The total purchase price of $7,000 was allocated to net working capital of $4,700 and intangibles of $2,300, taking into consideration projected revenue from the acquired list of Subsidiary’s customers over a period of five years.
Acquisition of Devcool, Inc.
On December 10, 2021, Healthcare Triangle, Inc. (the “Company”) entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with Devcool, Inc., a California corporation (“Devcool”), Go To Assistance Inc., a California corporation (“Seller”), and Mr. Sandeep Deokule, current Chief Executive Officer of Devcool (“SD”). Pursuant to the Share Purchase Agreement, the Company will acquire 5,000,000 shares of Devcool’s Class B Common Stock, par value $0.00001, which represents all of the issued and outstanding capital stock of Devcool (the “Acquisition”). The closing of the Acquisition occurred on December 10, 2021 (the “Closing Date”). The Company exercised control by virtue of taking over the operation from November 01, 2021 (effective date) and the financials have been consolidated from this date.
The aggregate purchase price for the acquisition of Devcool Inc was $7,773 consisting of;
| 1. | $4,500 payable to the Seller in cash on the Closing Date; |
| 2. | $700 worth of equity of the Company’s common stock (the “Common Stock”) whereby the number of shares of common stock issuable to Mr. Deokule will be calculated by dividing $700 by the volume weighted average price of the Company’s common stock as reported by Bloomberg Financial Markets or if Bloomberg Financial Markets is not then reporting such prices, by a comparable reporting service of national reputation (“VWAP”) for the 20 trading days immediately prior to the closing date of the Transaction. Such shares of common stock were issued as follows: |
| a) | 20,930 shares of unvested Common Stock were issued to the Seller, which shall vest upon Devcool meeting one of two gross revenue targets set forth in the Share Purchase Agreement; and |
| b) | 8,372 shares of unvested Common Stock were issued as retention bonus to certain key personnel of Devcool to be retained by Devcool post-Closing (the “Retention Personnel”), subject to the Retention Personnel continuing to perform services to Devcool (or its affiliates) up to and through the second anniversary of the closing date, which shares shall vest equally monthly on the corresponding day of the closing date over a period of 24 successive months; and |
| 3. | A sum of up to $2,500 as post-closing earnout payment (the “Earnout”), subject to Devcool’s achievement of the applicable yearly earnout targets set forth in the Share Purchase Agreement, which Earnout shall be payable as follows: |
| a) | up to $250 worth of Common Stock (calculated based on the average of the VWAPs for the 20 trading days immediately prior to December 31, 2022) issuable to SD or the Seller as SD’s nominee for achievement of the Year 1 Equity Earnout (as defined in Annexure B to the Share Purchase Agreement); |
| b) | up to $1,000 payable to the Seller or its nominees in cash upon achieving the Year 1 Cash Earnout; and |
| c) | up to $250 worth of Common Stock (calculated based on the average of the VWAPs for the 20 trading days immediately prior to December 31, 2023) issuable to SD or the Seller as SD’s nominee for achievement of the Year 2 Equity Earnout (as defined in Annexure B to the Share Purchase Agreement). |
| d) | up to $1,000 payable to the Seller or its nominees in cash upon achieving the Year 2 Cash Earnout; and |
| 4. | The Company also issued the Seller a secured non-interest-bearing promissory note in the principal amount of $2,209 that matures on April 30, 2022 (the “Note”) that reflects an amount owed to the Seller by the Company equal to the difference between the amount of accrued and outstanding accounts receivable on the Closing Date less the amount of accrued and outstanding accounts payable on the Closing Date. |
Based on the preliminary purchase price allocation, we recorded $1,289 of goodwill which is not tax deductible.
Presented below is the summary of the foregoing acquisitions
Allocation of purchase price
Schedule of allocation of purchase price
| Asset Component | Amount |
|---|---|
| Intangible Assets | $6,018 |
| Goodwill | 1,289 |
| Working Capital | — |
| Current Assets | |
| Cash | 970 |
| Accounts Receivables | 3,142 |
| Other Current Assets | |
| Other Current Assets | 11,419 |
| Current Liabilities | |
| Accounts Payable | 758 |
| Short term borrowing | 2,209 |
| Other Current liabilities | 679 |
| Current liabilities | 3,646 |
| Net Working Capital Acquired | 7,773 |
| Total Purchase price | $7,773 |
8) Debt Securities
A. Convertible Notes
In accordance with the terms outlined in the Security Purchase Agreement and First Tranche Note executed by the Company on December 28, 2023, the Company has commenced repayment of the convertible note. During the six months ended June 30, 2024, the company issued 794,004 shares at an average price of $1.66 and converted promissory note value of $1,181. The conversions resulted in no gains or losses as they were done as per the terms in the Convertible note agreement.
The convertible note outstanding as of June 30, 2024, is $585, reported under short-term borrowings.
| Convertible note | June 30, 2024 | December 31, 2023 |
|---|---|---|
| Short term borrowing | 585 | 1,112 |
| Long-term liabilities | - | 888 |
| Total Outstanding Debt | 585 | 2,000 |
| Date of Conversion | Installment | Loan | Interest | Repayment | Conversion price | No of shares |
|---|---|---|---|---|---|---|
| 2/14/2024 | 1 | $125,000 | $6,250 | $131,250 | 1.93 | 68,005 |
| 2/14/2024 | 2 | $125,000 | $6,250 | $131,250 | 1.93 | 68,005 |
| 3/1/2024 | 3 | $125,000 | $6,250 | $131,250 | 1.92 | 68,359 |
| 3/1/2024 | 4 | $125,000 | $6,250 | $131,250 | 1.92 | 68,359 |
| 3/1/2024 | 5 | $125,000 | $6,250 | $131,250 | 1.92 | 68,359 |
| 3/19/2024 | 6 | $125,000 | $6,250 | $131,250 | 1.72 | 76,308 |
| 4/23/2024 | 7 | $125,000 | $6,250 | $131,250 | 1.27 | 103,346 |
| 5/9/2024 | 8 | $125,000 | $6,250 | $131,250 | 1.15 | 114,130 |
| 5/9/2024 | 9 | $125,000 | $6,250 | $131,250 | 1.15 | 114,133 |
| Total | $1,125,000 | $56,250 | $1,181,250 | 1.66 | 749,004 |
Common Stock Warrants
The Company has issued warrants which entitles the holder thereof to purchase a number of shares of our common stock with such warrant. The warrants are convertible into common stock at a price equal to $7.99 per share.
The warrants are subject to certain customary adjustments in the event of stock dividends and splits, issuance of options, subsequent rights offerings, and pro rata distributions.
As of June 30, 2024, none of the warrants have been exercised by the note holders and hence no proceeds have been received towards any of the warrants.
The Warrants have been valued using the Black-Scholes-Merton Option (“BSM”) pricing model that is based on the individual characteristics of the warrants on the valuation date, which include the Company’s stock fair value and assumptions for expected volatility, expected life and risk-free interest rate, as well as the present value of the minimum cash payment component of the instrument for the warrants, when applicable. Changes in the assumptions used could have a material impact on the resulting fair value of each warrant. The primary inputs affecting the value of the warrant liability are the Company’s stock price and volatility in the Company’s stock price, as well as assumptions about the probability and timing of certain events, such as a change in control or future equity offerings. Increases in the fair value of the underlying stock or increases in the volatility of the stock price generally result in a corresponding increase in the fair value of the warrant liability; conversely, decreases in the fair value of the underlying stock or decreases in the volatility of the stock price generally result in a corresponding decrease in the fair value of the warrant liability.
Schedule of common stock warrants
| Warrants | Number of Warrants | Weighted Average Exercise price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic value |
|---|---|---|---|---|
| Outstanding on January 1, 2024 | 967,256 | $7.99 | 4.07 | 3,785 |
| Granted | — | — | — | — |
| Exercised | — | — | — | — |
| Forfeited or expired | — | — | — | — |
| Outstanding on June 30, 2024 | 967,256 | $7.99 | 3.82 | 3,785 |
| Exercisable on June 30, 2024 | 279,653 | $7.99 | 3.82 | 1,333 |
The following table summarizes the activities for our unvested warrants for the quarter ended June 30, 2024
Schedule of unvested warrants
| Number of Warrants | Weighted average Grant Date Fair Value Per warrant | |
|---|---|---|
| Unvested on January 1, 2024 | 784,329 | $3.91 |
| Granted | — | |
| Vested | (96,726) | $3.91 |
| Forfeited | — | |
| Unvested on June 30, 2024 | 687,603 | $3.91 |
The Company has recognized cost of $190 for the quarter ended June 30, 2024, and $190 for the quarter ended June 30, 2023.
B. Warrant Liability
The Company has allocated the proceeds from convertible note between promissory notes and warrants; as of June 30, 2024, the Company has reported a Warrant liability of $1,333 at fair value, with subsequent changes in their respective fair values recognized in the consolidated statement of operations at each reporting date.
The fair value of the warrant liabilities was measured using a binomial lattice model. Significant inputs into the model at the inception and reporting period measurement dates are as follows:
| Schedule of fair value of warrant liabilities | |
|---|---|
| Fair value assumptions | June 30, 2024 |
| Estimated fair value of common stock warrant | $3.91 |
| Exercise price | $7.99 |
| Expected volatility | 45%-52% |
| Expected terms (in years) | 5 |
| Risk-free interest rate | 4.60%-5.46% |
| Dividend Yield | 0% |
C. Short Term borrowing
Seacoast Business Funding:
The Company has obtained a credit facility from Seacoast business funding (SBF), a division of Seacoast National Bank. The funding is against the accounts receivables of the company and its subsidiary. The SBF facility charges an interest of prime rate plus 1% on a floating basis. The balance as of June 30, 2024, is $1,141 and $3,429 for the period ended December 31, 2023.
Convertible Note:
The Company entered into a securities purchase agreement on December 28, 2023 and issued convertible promissory notes in the principal amount of $2,000. The balance as of June 30, 2024, is $585,
| Short term borrowing | June 30, 2024 | December 31, 2023 |
|---|---|---|
| Seacoast business funding (SBF) | $1,141 | $2,317 |
| Convertible note | $585 | $1,112 |
| Total short-term borrowing | $1,726 | $3,429 |
9) Provision for Income Taxes
The Company accounts for income taxes in accordance with FASB ASC Topic 740,Income Taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Management evaluates all available evidence about future taxable income and other possible sources of realization of deferred tax assets. A valuation allowance is established to reduce deferred tax assets to an amount that represents management’s best estimate of the amount of such deferred tax assets that more likely than not will be realized. To the extent the Company establishes a valuation allowance or increased the allowance in any given period, an expense is recognized within the provision for income taxes in the statement of income.
The Company recognizes the tax benefit from uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the tax authorities, based on the technical merits of the position. The tax benefit is measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement. The Company recognizes interest and penalties related to income tax matters as other expense in the statement of income. Based on management’s evaluations, there are no uncertain tax positions requiring recognition as of the date of these financial statements.
The components of the Company’s net deferred tax assets as of June 30, 2024 and December 31, 2023, were as follows (in thousands):
| Schedule of deferred tax assets | ||
|---|---|---|
| June 30, 2024 | December 31, 2023 | |
| Deferred tax assets: | ||
| Net Operating loss carry forward | $4,042 | $3,322 |
| Stock-based compensation | (14) | (18) |
| Warrants | (102) | (172) |
| Total Deferred tax asset | 3,926 | 3,132 |
| Less: Valuation allowance | $(3,926) | $(3,132) |
| Deferred tax asset. net of valuation allowance | — | — |
| Deferred tax liabilities | — | — |
| Net Deferred tax asset | — | — |
Income tax expense (benefit) was computed as follows:
| Schedule of income tax expense benefit | ||
|---|---|---|
| June 30, 2024 | June 30, 2023 | |
| Federal income tax | $— | $— |
| State income tax | 1 | 5 |
| Total Income taxes , Current provision | 1 | 5 |
| Deferred Income taxes (benefit) | — | — |
| Total Income expenses (benefit) | $1 | $5 |
The Company’s effective tax rate is 0% for the quarter ended June 30, 2024 and 0% and for the quarter ended June 30, 2023 The future effective income tax rate depends on various factors, such as the Company’s income (loss) before taxes, tax legislation and the geographic composition of pre-tax income.
The Company files a consolidated federal tax return with its parent and records its share of the consolidated federal tax expense on a separate return basis. The Company’s current tax expense isnil. There is no liability in 2023 on account of losses.
The Company’s federal and state income tax returns are generally subject to possible examination by the taxing authorities until the expiration of the related statute of limitations on those tax returns which is generally three years from the original filing deadline. The Company regularly reviews its deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing taxable temporary differences and tax planning strategies. The Company’s judgment regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute the business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the Company’s income tax provision would increase or decrease in the period in which the assessment is changed.
10) New Accounting Pronouncements
i)ASU 2021-08*—Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.*For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption of the amendments is permitted, including adoption in an interim period. The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its consolidated financial statements.
(ii)ASU 2021-10*—Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.*The amendments in this Update are effective for all entities within their scope for financial statements issued for annual periods beginning after December 15, 2021. Early application of the amendments is permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its consolidated financial statements.
11) Legal Matters
The Company is not involved in any action, arbitration and/or other legal proceedings that it expects to have a material adverse effect on the business, financial condition, results of operations or liquidity of the Company. All legal costs are expensed as incurred.
12) Share Based Compensation
We estimate the fair value of our stock options using the Black-Scholes option pricing model. This requires the input of subjective assumptions, including the fair value of our underlying common stock, the expected term of stock options, the expected volatility of the price of our common stock, risk-free interest rates, and the expected dividend yield of our common stock, the most critical of which, prior to our IPO, was the estimated fair value of common stock. The assumptions used in our option pricing model represent our best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future. The resulting fair value, net of actual forfeitures, is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award
These assumptions used in the Black-Scholes option pricing model, other than the fair value of our common stock, are estimated as follows:
| ● | Expected volatility. Since a public market for our common stock did not exist prior to our IPO in October 2021 and, therefore, we do not have an extensive trading history of our common stock, we estimated the expected volatility based on the volatility of similar publicly-held entities (guideline companies) over a period equivalent to the expected term of the awards. In evaluating the similarity of guideline companies to us, we considered factors such as industry, stage of life cycle, size, and financial leverage. We intend to continue to consistently apply this process using the same or similar guideline companies to estimate the expected volatility until sufficient historical information regarding the volatility of the share price of our common stock becomes available. |
| ● | Expected term. We estimate the expected term using the simplified method, as we do not have sufficient historical exercise activity to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the average period the stock options are expected to remain outstanding as the midpoint between the vesting date and the contractual expiration date of the award. |
| ● | Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for maturities corresponding with the expected term of the option. |
| ● | Expected dividend yield. We have never declared or paid any dividends and do not presently plan to pay dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero. |
We are required to estimate the fair value of the common stock underlying our stock-based awards when performing fair value calculations.
Historically for all periods prior to our IPO, given the absence of a public trading market for our common stock, and in accordance with the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held Company Equity Securities Issued as Compensation, we exercised reasonable judgment and considered numerous objective and subjective factors to determine the best estimate of the fair value of our common stock including:
| ● | contemporaneous valuations performed at periodic intervals by unrelated third-party specialists |
| ● | our actual operating and financial performance. |
| ● | relevant precedent transactions involving our capital stock. |
| ● | likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given prevailing market conditions and the nature and history of our business. |
| ● | market multiples of comparable companies in our industry. |
| ● | stage of development. |
| ● | industry information such as market size and growth. |
| ● | illiquidity of stock-based awards involving securities in a private company; and |
In valuing our common stock prior to our IPO, our board of directors determined the enterprise value of our company using both the income approach and market approach valuation methods. The income approach estimates value based on the expectation of future cash flows that a company will generate. These future cash flows are discounted to their present values using a discount rate based on the cost of capital at a company’s stage of development. The market approach estimates value based on a comparison of the subject company to comparable public companies in a similar line of business. From the comparable companies, a representative market value multiple is determined and then applied to the subject company’s financial results to estimate the enterprise value of the subject company.
A summary of option activity under the employee share option plan as of June 30, 2024, and changes during the year then period is presented below.
Schedule of stock option activity
| Options · Shares of Stock | |||||
|---|---|---|---|---|---|
| No. of Options | Weighted Average Price | No. of Shares | Weighted Average Price | Total | |
| Balance outstanding as at January 1, 2024 | 538,265 | — | — | — | 538,265 |
| Granted | (20,000) | 1.78 | (20,000) | ||
| Incentive Stock Options (ISO) | — | — | — | — | |
| Non-Qualified Stock Options (NSO) | — | — | — | ||
| Cancelled/expired/exercised | 17,110 | — | — | 17,110 | |
| Balance available under the plan as of March 31, 2024 | 535,375 | — | — | — | 535,375 |
| Cancelled/expired/exercised | — | — | — | ||
| Issued | (7,531) | — | — | (7,531) | |
| Balance available under the plan as of June 30, 2024 | 527,844 | — | — | — | 527,844 |
The following table summarizes the activities for our unvested options for the quarter ended June 30, 2024
| Schedule of unvested options | ||
|---|---|---|
| Number of options | Weighted average Grant Date Fair Value Per Option | |
| Unvested on December 31, 2023 | 135,377 | 4.00 |
| Granted | — | — |
| Vested | (21,807) | 3.58 |
| Forfeited | (17,616) | 4.22 |
| Unvested on March 31, 2024 | 95,954 | 4.00 |
| Granted | — | — |
| Vested | (12,799) | 3.84 |
| Forfeited | — | |
| Unvested on June 30, 2024 | 83,155 | 4.00 |
The weighted-average grant date fair value of options granted during the quarter ended June 30, 2024 was$0 and$0 during the quarter ended March 31, 2024. The fair value as of the respective vesting dates of options that vested during the quarter ended June 30, 2024, was $491 and $119 during the quarter ended March 31, 2024.
As of June 30, 2024, there was $94 of unrecognized share-based compensation expense related to unvested options. This unrecognized compensation expense is expected to be recognized over a weighted-average period of approximatelytwo years based on vesting under the award service conditions.
| Schedule of assumptions | ||
|---|---|---|
| Fair value assumptions | 2024 | 2023 |
| Expected volatility | 45%-52% | 45%-52% |
| Expected terms (in years) | 2 | 2 |
| Risk-free interest rate | 2.18%-3.57% | 2.18%-3.57% |
| Dividend Yield | 0% | 0% |
13) Net Income per share
The Company presents basic and diluted earnings per share (“EPS”) data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements.
The Company’s unvested restricted stock awards are considered participating securities under FASB Codification topic,Earnings Per Share, because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a “participating security,” the Codification requires the use of the two-class method when computing basic EPS. The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net income to allocate to common stockholders, income is allocated to both common stock and participating securities based on their respective weighted average shares outstanding for the period, with net income attributable to common stockholders ultimately equaling net income less net income attributable to participating securities. Diluted EPS for the Company’s common stock is computed using the more dilutive of the two-class method or the treasury stock method.
The company has 261,777 warranties that are exercisable at weighted average price of $7.99 on June 30, 2024, and 90,923 warrant that are exercisable at weighted average price of $28.80 at June 30, 2023.
The company has 217,790 options that are vested and exercisable on June 30, 2024.
| Schedule of earning per share | ||
|---|---|---|
| Three Months Ended June 30, | ||
| 2024 | 2023 | |
| Net income attributable to common stockholders | $(1,510) | $(1,786) |
| Weighted average shares outstanding used in basic per common share computations | 5,316,376 | 4,273,142 |
| Basic /Diluted EPS | $(0.28) | $(0.42) |
14) Subsequent Events
For the quarter ended June 30, 2024, the Company has evaluated subsequent events through August 19, 2024. The company has issued 50,000 common shares at $0.48 per share for services, after the quarter ended June 30, 2024, which the financial statements were available to be issued.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.